Related Experiment Video
Updated: Jun 17, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Multisystemic Inflammatory Syndrome in Children, A Disease with Too Many Faces: A Single-Center Experience
Alina Grama1,2, Simona Sorana Căinap1,2, Alexandra Mititelu2
1Pediatric Discipline, Department of Mother and Child, Iuliu Hațieganu University of Medicine and Pharmacy, 400177 Cluj-Napoca, Romania.
Insights
Multisystemic inflammatory syndrome in children (MIS-C) linked to SARS-CoV-2 infection presents with diverse severity. Severe MIS-C cases show significant organ dysfunction and require intensive care, with some developing long-term complications.
Area of Science:
- Pediatric infectious diseases
- Immunology
- Critical care medicine
Background:
- Multisystemic inflammatory syndrome in children (MIS-C) is a rare but severe condition following SARS-CoV-2 infection.
- The exact mechanisms, risk factors, and disease progression of MIS-C remain incompletely understood.
- This study addresses the need for detailed clinical descriptions and risk factor analysis of MIS-C in pediatric populations.
Purpose of the Study:
- To describe the clinical features, treatment strategies, and outcomes of MIS-C in hospitalized children.
- To identify key risk factors associated with severe forms of MIS-C.
- To analyze the disease evolution and long-term complications in pediatric MIS-C patients.
Main Methods:
- A retrospective study was conducted over 13 months (November 2020-December 2021).
- The study included 34 children diagnosed with MIS-C based on established criteria.
- Data collected included clinical manifestations, laboratory findings, treatment interventions, and patient outcomes.
Main Results:
- The cohort included 34 children (mean age 6.8 years) with MIS-C, characterized by fever and organ dysfunction.
- Over half (55.88%) presented with severe disease, including multiorgan failure and shock.
- Severe MIS-C cases exhibited significantly higher organ involvement and specific laboratory abnormalities (e.g., hypoalbuminemia, hyponatremia), necessitating aggressive medical support.
Conclusions:
- MIS-C presents a spectrum from mild to severe forms, posing diagnostic and management challenges for pediatricians.
- Early recognition and awareness of potential severe evolution and complications are crucial for optimal patient care.
- The study highlights the critical need for vigilant monitoring and prompt intervention in pediatric patients with MIS-C.
Background And Aim:
Multisystemic inflammatory syndrome in children (MIS-C) is a rare and severe condition associated with Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) infection in children with onset approximately 4-6 weeks after infection. To date, the precise mechanism that causes MIS-C is not known and there are many questions related to the etiology, risk factors, and evolution of this syndrome. We aimed to describe the clinical manifestations, treatment methods, and disease evolution and analyze the main risk factors for MIS-C in children hospitalized in our clinic.
Material And Methods:
We performed a retrospective study including children with MIS-C followed-up in the 2nd Pediatric Clinic of the Emergency Clinical Hospital for Children Cluj-Napoca, Romania, for 13 months (November 2020-December 2021).
Results:
We included in our cohort 34 children (mean age 6.8 ± 4.6 years) who met MIS-C criteria: high and prolonged fever associated with organ dysfunction (heart, lungs, kidneys, brain, skin, eyes, bone marrow or gastrointestinal organs), and autoantibodies and/or polymerase chain reaction positives for SARS-CoV-2. Nineteen patients (55.88%) had a severe form of the disease, with multiorgan failure and shock, and myocardial or respiratory failure. The number of organs affected in the severe forms was significantly higher (more than 6 in 73.70%) than in mild forms (2-3 in 60%). Cardiac dysfunction, hypoalbuminemia, hypertriglyceridemia and hyponatremia were more important in severe forms of MIS-C. These patients required respiratory support, resuscitation with fluid boluses, vasoactive drugs, or aggressive therapy. All patients with mild forms had fully recovered compared to 63.16% in severe forms. The others with severe forms developed long-term complications (dilation of the coronary arteries, premature ventricular contraction, or myocardial fibrosis). Two patients had an extremely severe evolution. One is still waiting for a heart transplant, and the other died (hemophagocytic lymphohistiocytosis syndrome with multiorgan failure).
Conclusions:
From mild to severe forms with multiorgan failure, shock, and many other complications, MIS-C represents a difficult challenge for pediatricians, who must be aware of the correct diagnosis and unpredictable, possibly severe evolution.
Related Concept Videos
Cytomegalovirus Disease
Respiratory Syncytial Virus Disease
Multiple Sclerosis l: Introduction
Inflammatory Bowel Disease IV: Clinical Manifestations
Hypersensitivity Reactions: Immune-Complex Reactions

